Overview

The Rose-Waaler test is a historical serological test used to detect rheumatoid factor (RF) in the blood. Rheumatoid factor is an autoantibody associated with rheumatoid arthritis (RA) and other autoimmune conditions. While this test was widely used in the past, it has largely been replaced by more advanced methods like latex agglutination, nephelometry, and ELISA for detecting RF.

Test Principle

The Rose-Waaler test is a hemagglutination test where sheep red blood cells (SRBCs) are coated with rabbit IgG antibodies. When mixed with a patient's serum containing RF (usually IgM), visible agglutination occurs, indicating the presence of RF.

Risk Assessment & Clinical Significance

1. Indications for the Test

• Diagnosis of rheumatoid arthritis (RA)
• Monitoring disease progression
• Differentiating autoimmune disorders

2. Conditions Associated with Positive Results

• Rheumatoid arthritis (RA) (80% of RA patients have RF)
• Other autoimmune diseases (e.g., Sjögren’s syndrome, lupus)
• Chronic infections (e.g., tuberculosis, hepatitis)
• Certain malignancies

3. Limitations & Risks

• False Positives: Can occur in healthy individuals or due to infections.
• False Negatives: RF may be absent in early-stage RA or in seronegative RA cases.
• Low Specificity: RF is not exclusive to RA and may be present in other conditions.

Normal Range

• Negative or RF titer <1:20
• Some labs may express RF in IU/mL, with a normal range <14 IU/mL.

Interpretation of Results

Note: Higher titers correlate with more severe disease and extra-articular manifestations in RA.

Sample Type & Collection

• Sample Type: Serum (collected from venous blood)
• Collection Requirements:
  • 3–5 mL venous blood in a red-top or serum separator tube (SST)
  • Allow blood to clot and separate serum by centrifugation
  • Avoid hemolysis, as it may affect test accuracy.